JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18–26; doi: 10.1089/psymed.2022.0002

Psychedelic Medicine May 3, 2024 correction DOI: 10.1089/psymed.2022.0002.correx (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Topics	Anxiety Psilocybin Depression
Keywords	Escitalopram Depression economics Hallucinogen

Abstract

[This corrects the article DOI: 10.1089/psymed.2022.0002.].

Explore topics

Anxiety Psilocybin Depression

By condition and practice

Psilocybin for anxiety Psilocybin for depression